Anti-Myeloperoxidase antibody - Carboxyterminal end (ab65871)

Abreviews (3) Submit a Question Specific References (4)

Publishing research using ab65871? Please let us know so that we can cite the reference in this datasheet.

ab65871 has been referenced in 4 publications.

  • Jing W  et al. LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD. Am J Transl Res 9:5473-5484 (2017). WB ; Rat . PubMed: 29312499
  • Hermann S  et al. Imaging Reveals the Connection Between Spontaneous Coronary Plaque Ruptures, Atherothrombosis, and Myocardial Infarctions in HypoE/SRBI-/- Mice. J Nucl Med 57:1420-7 (2016). PubMed: 27127225
  • Zhang M  et al. CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion. Int J Clin Exp Pathol 8:3491-502 (2015). PubMed: 26097533
  • Zhang H  et al. Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. J Lipid Res 54:3009-15 (2013). Mouse . PubMed: 23956444

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up